In regards to the Pfizer partnership - Athersys expects top line data for its Phase II study for patients with moderate to severe ulcerative colitis in 2014.
You just said it again. This is dead money until 2014. That's at least 3 months away. Dilution should happen this Q4. No sense in going long until that happens.